English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
GlobalData on MSN
23 小时
BlueRock accelerates Parkinson’s disease therapy to Phase III
The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...
New Atlas
1 小时
Michael J. Fox funds early warning Parkinson's biomarker initiative
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
来自MSN
1 小时
Deep brain stimulation to see high usage in Parkinson’s: report
It can improve motor symptoms, including tremors. Deep brain stimulation (DBS) will continue to see high usage in Parkinson’s ...
17 小时
on MSN
Focused ultrasound machine can stop Parkinson's tremors
Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement ...
UK Fundraising
1 小时
Parkinson’s UK updates branding to improve accessibility & relevance to everyone impacted ...
Parkinson’s UK has today (15 January) revealed updated branding, including a new logo and strapline, and a bespoke accessible ...
21 小时
Ex-Jets QB opens up about Parkinson’s diagnosis
In September, longtime Packers quarterback Brett Favre revealed that he had been diagnosed with Parkinson’s disease. He ...
18 小时
on MSN
Dr. Adeel Khan Discussing Safer Stem Cell Therapies on Power Athlete Radio
In this clip from Power Athlete Radio Episode 746, Dr. Adeel Khan explores the incredible potential of induced pluripotent stem cells (iPSCs) for treating conditions like Parkinson’s disease.
22 小时
First Participants Randomized In Askbio Phase II Gene Therapy Trial For Parkinson’S Disease
Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK <a target=_blank href=https ...
Healio
20 小时
Allosteric modulator nonsuperior to placebo in Parkinson’s disease
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
41 分钟
CB Therapeutics Breaks Ground on Sustainable Ergoline Biosynthesis Through Precision ...
CARLSBAD, CA / ACCESSWIRE / January 15, 2025 / CB Therapeutics, a U.S.-based synthetic biology company known for its ...
15 小时
on MSN
Molecule shown to produce cognitive improvement in rodents with early Alzheimer's disease
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈